Education
About Us
Working with TipRanks
Follow Us
Tenaya Therapeutics, Inc. (TNYA)
:TNYA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -8.69M | $ -8.71M | $ -4.03M | $ -2.48M |
| Operating Income | $ -115.95M | $ -131.19M | $ -125.62M | $ -72.81M | $ -38.91M |
| EBITDA | $ -115.95M | $ -122.51M | $ -114.95M | $ -68.70M | $ -36.43M |
| Net Income | $ -111.13M | $ -124.08M | $ -123.66M | $ -69.65M | $ -38.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 61.45M | $ 104.64M | $ 204.23M | $ 251.30M | $ 128.53M |
| Total Assets | $ 119.94M | $ 170.51M | $ 278.94M | $ 314.19M | $ 148.16M |
| Total Debt | $ 13.61M | $ 12.42M | $ 15.10M | $ 13.71M | $ 0.00 |
| Net Debt | $ 9.29M | $ -33.26M | $ -80.17M | $ -24.42M | $ -128.53M |
| Total Liabilities | $ 27.09M | $ 31.09M | $ 278.94M | $ 35.66M | $ 229.48M |
| Stockholders' Equity | $ 92.85M | $ 139.42M | $ 243.38M | $ 278.53M | $ -81.31M |
| Cash Flow | |||||
| Free Cash Flow | $ -91.53M | $ -103.31M | $ -125.05M | $ -85.93M | $ -45.21M |
| Operating Cash Flow | $ -90.50M | $ -102.07M | $ -104.42M | $ -60.81M | $ -35.45M |
| Investing Cash Flow | $ 1.13M | $ 48.72M | $ 83.65M | $ -238.56M | $ -7.01M |
| Financing Cash Flow | $ 47.75M | $ 4.05M | $ 77.77M | $ 208.97M | $ 147.27M |